XOMA Corp (XOMA) Spikes on Positive Data

XOMA Corp (NASDAQ: XOMA) rose 16.8% to $7.59 after the company reported the presentation of positive data from its anti-PTH1R antagonist monoclonal antibody program. Share volume was 423,000, compared to an all-day average of 132,000